▶ 調査レポート

世界の甲状腺障害市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Thyroid Disorder Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の甲状腺障害市場 2021:企業別、地域別、種類・用途別 / Global Thyroid Disorder Market 2021 by Company, Regions, Type and Application, Forecast to 2026 / GIR-2104Z13887資料のイメージです。• レポートコード:GIR-2104Z13887
• 出版社/出版日:GlobalInfoResearch / 2021年3月15日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療・医薬品
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、甲状腺障害のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。甲状腺障害の種類別市場規模(甲状腺機能低下症、甲状腺機能亢進症)、用途別市場規模(病院、診療所、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・甲状腺障害の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Pfizer Inc、Allergan、AbbVie Inc.、Merck KGaA、RLC Labs、GlaxoSmithKline Plc、Mylan
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:甲状腺機能低下症、甲状腺機能亢進症
・用途別分析2016年-2026年:病院、診療所、その他
・甲状腺障害の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・甲状腺障害のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・甲状腺障害のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・甲状腺障害の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・甲状腺障害の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Thyroid Disorder market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Thyroid Disorder size is estimated to be USD 2944.6 million in 2025 from USD 2725.4 million in 2019, with a change XX% between 2019 and 2020. The global Thyroid Disorder market size is expected to grow at a CAGR of 2.0% for the next five years.

Market segmentation
Thyroid Disorder market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Hypothyroidism
Hyperthyroidism

Market segment by Application, can be divided into
Hospitals
Clinics
Others

Market segment by players, this report covers
Pfizer Inc
Allergan
AbbVie Inc.
Merck KGaA
RLC Labs
GlaxoSmithKline Plc
Mylan

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Thyroid Disorder
1.2 Classification of Thyroid Disorder by Type
1.2.1 Overview: Global Thyroid Disorder Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Thyroid Disorder Revenue Market Share by Type in 2020
1.2.3 Hypothyroidism
1.2.4 Hyperthyroidism
1.3 Global Thyroid Disorder Market by Application
1.3.1 Overview: Global Thyroid Disorder Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Thyroid Disorder Market Size & Forecast
1.5 Global Thyroid Disorder Market Size and Forecast by Region
1.5.1 Global Thyroid Disorder Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Thyroid Disorder Market Size by Region, (2016-2021)
1.5.3 North America Thyroid Disorder Market Size and Prospect (2016-2026)
1.5.4 Europe Thyroid Disorder Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Thyroid Disorder Market Size and Prospect (2016-2026)
1.5.6 South America Thyroid Disorder Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Thyroid Disorder Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Thyroid Disorder Market Drivers
1.6.2 Thyroid Disorder Market Restraints
1.6.3 Thyroid Disorder Trends Analysis
2 Company Profiles
2.1 Pfizer Inc
2.1.1 Pfizer Inc Details
2.1.2 Pfizer Inc Major Business
2.1.3 Pfizer Inc Thyroid Disorder Product and Solutions
2.1.4 Pfizer Inc Thyroid Disorder Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Inc Recent Developments and Future Plans
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Thyroid Disorder Product and Solutions
2.2.4 Allergan Thyroid Disorder Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Allergan Recent Developments and Future Plans
2.3 AbbVie Inc.
2.3.1 AbbVie Inc. Details
2.3.2 AbbVie Inc. Major Business
2.3.3 AbbVie Inc. Thyroid Disorder Product and Solutions
2.3.4 AbbVie Inc. Thyroid Disorder Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 AbbVie Inc. Recent Developments and Future Plans
2.4 Merck KGaA
2.4.1 Merck KGaA Details
2.4.2 Merck KGaA Major Business
2.4.3 Merck KGaA Thyroid Disorder Product and Solutions
2.4.4 Merck KGaA Thyroid Disorder Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Merck KGaA Recent Developments and Future Plans
2.5 RLC Labs
2.5.1 RLC Labs Details
2.5.2 RLC Labs Major Business
2.5.3 RLC Labs Thyroid Disorder Product and Solutions
2.5.4 RLC Labs Thyroid Disorder Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 RLC Labs Recent Developments and Future Plans
2.6 GlaxoSmithKline Plc
2.6.1 GlaxoSmithKline Plc Details
2.6.2 GlaxoSmithKline Plc Major Business
2.6.3 GlaxoSmithKline Plc Thyroid Disorder Product and Solutions
2.6.4 GlaxoSmithKline Plc Thyroid Disorder Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 GlaxoSmithKline Plc Recent Developments and Future Plans
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business
2.7.3 Mylan Thyroid Disorder Product and Solutions
2.7.4 Mylan Thyroid Disorder Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Mylan Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Thyroid Disorder Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Thyroid Disorder Players Market Share
3.2.2 Top 10 Thyroid Disorder Players Market Share
3.2.3 Market Competition Trend
3.3 Thyroid Disorder Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Thyroid Disorder Revenue and Market Share by Type (2016-2021)
4.2 Global Thyroid Disorder Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Thyroid Disorder Revenue Market Share by Application (2016-2021)
5.2 Thyroid Disorder Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Thyroid Disorder Revenue by Type (2016-2026)
6.2 North America Thyroid Disorder Revenue by Application (2016-2026)
6.3 North America Thyroid Disorder Market Size by Country
6.3.1 North America Thyroid Disorder Revenue by Country (2016-2026)
6.3.2 United States Thyroid Disorder Market Size and Forecast (2016-2026)
6.3.3 Canada Thyroid Disorder Market Size and Forecast (2016-2026)
6.3.4 Mexico Thyroid Disorder Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Thyroid Disorder Revenue by Type (2016-2026)
7.2 Europe Thyroid Disorder Revenue by Application (2016-2026)
7.3 Europe Thyroid Disorder Market Size by Country
7.3.1 Europe Thyroid Disorder Revenue by Country (2016-2026)
7.3.2 Germany Thyroid Disorder Market Size and Forecast (2016-2026)
7.3.3 France Thyroid Disorder Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Thyroid Disorder Market Size and Forecast (2016-2026)
7.3.5 Russia Thyroid Disorder Market Size and Forecast (2016-2026)
7.3.6 Italy Thyroid Disorder Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Thyroid Disorder Revenue by Type (2016-2026)
8.2 Asia-Pacific Thyroid Disorder Revenue by Application (2016-2026)
8.3 Asia-Pacific Thyroid Disorder Market Size by Region
8.3.1 Asia-Pacific Thyroid Disorder Revenue by Region (2016-2026)
8.3.2 China Thyroid Disorder Market Size and Forecast (2016-2026)
8.3.3 Japan Thyroid Disorder Market Size and Forecast (2016-2026)
8.3.4 South Korea Thyroid Disorder Market Size and Forecast (2016-2026)
8.3.5 India Thyroid Disorder Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Thyroid Disorder Market Size and Forecast (2016-2026)
8.3.7 Australia Thyroid Disorder Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Thyroid Disorder Revenue by Type (2016-2026)
9.2 South America Thyroid Disorder Revenue by Application (2016-2026)
9.3 South America Thyroid Disorder Market Size by Country
9.3.1 South America Thyroid Disorder Revenue by Country (2016-2026)
9.3.2 Brazil Thyroid Disorder Market Size and Forecast (2016-2026)
9.3.3 Argentina Thyroid Disorder Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Thyroid Disorder Revenue by Type (2016-2026)
10.2 Middle East & Africa Thyroid Disorder Revenue by Application (2016-2026)
10.3 Middle East & Africa Thyroid Disorder Market Size by Country
10.3.1 Middle East & Africa Thyroid Disorder Revenue by Country (2016-2026)
10.3.2 Turkey Thyroid Disorder Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Thyroid Disorder Market Size and Forecast (2016-2026)
10.3.4 UAE Thyroid Disorder Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Thyroid Disorder Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Thyroid Disorder Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Thyroid Disorder Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Thyroid Disorder Revenue (USD Million) by Region (2016-2021)
Table 5. Global Thyroid Disorder Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Inc Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Inc Major Business
Table 8. Pfizer Inc Thyroid Disorder Product and Solutions
Table 9. Pfizer Inc Thyroid Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Allergan Corporate Information, Head Office, and Major Competitors
Table 11. Allergan Major Business
Table 12. Allergan Thyroid Disorder Product and Solutions
Table 13. Allergan Thyroid Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. AbbVie Inc. Corporate Information, Head Office, and Major Competitors
Table 15. AbbVie Inc. Major Business
Table 16. AbbVie Inc. Thyroid Disorder Product and Solutions
Table 17. AbbVie Inc. Thyroid Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Merck KGaA Corporate Information, Head Office, and Major Competitors
Table 19. Merck KGaA Major Business
Table 20. Merck KGaA Thyroid Disorder Product and Solutions
Table 21. Merck KGaA Thyroid Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. RLC Labs Corporate Information, Head Office, and Major Competitors
Table 23. RLC Labs Major Business
Table 24. RLC Labs Thyroid Disorder Product and Solutions
Table 25. RLC Labs Thyroid Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. GlaxoSmithKline Plc Corporate Information, Head Office, and Major Competitors
Table 27. GlaxoSmithKline Plc Major Business
Table 28. GlaxoSmithKline Plc Thyroid Disorder Product and Solutions
Table 29. GlaxoSmithKline Plc Thyroid Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Mylan Corporate Information, Head Office, and Major Competitors
Table 31. Mylan Major Business
Table 32. Mylan Thyroid Disorder Product and Solutions
Table 33. Mylan Thyroid Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Thyroid Disorder Revenue (USD Million) by Players (2019-2021)
Table 35. Global Thyroid Disorder Revenue Share by Players (2019-2021)
Table 36. Breakdown of Thyroid Disorder by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Thyroid Disorder Players Head Office, Products and Services Provided
Table 38. Thyroid Disorder Mergers & Acquisitions in the Past Five Years
Table 39. Thyroid Disorder New Entrants and Expansion Plans
Table 40. Global Thyroid Disorder Revenue (USD Million) by Type (2016-2021)
Table 41. Global Thyroid Disorder Revenue Share by Type (2016-2021)
Table 42. Global Thyroid Disorder Revenue Forecast by Type (2021-2026)
Table 43. Global Thyroid Disorder Revenue by Application (2016-2021)
Table 44. Global Thyroid Disorder Revenue Forecast by Application (2021-2026)
Table 45. North America Thyroid Disorder Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Thyroid Disorder Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Thyroid Disorder Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Thyroid Disorder Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Thyroid Disorder Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Thyroid Disorder Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Thyroid Disorder Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Thyroid Disorder Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Thyroid Disorder Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Thyroid Disorder Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Thyroid Disorder Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Thyroid Disorder Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Thyroid Disorder Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Thyroid Disorder Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Thyroid Disorder Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Thyroid Disorder Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Thyroid Disorder Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Thyroid Disorder Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Thyroid Disorder Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Thyroid Disorder Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Thyroid Disorder Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Thyroid Disorder Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Thyroid Disorder Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Thyroid Disorder Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Thyroid Disorder Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Thyroid Disorder Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Thyroid Disorder Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Thyroid Disorder Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Thyroid Disorder Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Thyroid Disorder Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Thyroid Disorder Picture
Figure 2. Global Thyroid Disorder Revenue Market Share by Type in 2020
Figure 3. Hypothyroidism
Figure 4. Hyperthyroidism
Figure 5. Thyroid Disorder Revenue Market Share by Application in 2020
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Others Picture
Figure 9. Global Thyroid Disorder Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Thyroid Disorder Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Thyroid Disorder Revenue Market Share by Region (2016-2026)
Figure 12. Global Thyroid Disorder Revenue Market Share by Region in 2020
Figure 13. North America Thyroid Disorder Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Thyroid Disorder Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Thyroid Disorder Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Thyroid Disorder Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Thyroid Disorder Market Drivers
Figure 18. Thyroid Disorder Market Restraints
Figure 19. Thyroid Disorder Market Trends
Figure 20. Pfizer Inc Recent Developments and Future Plans
Figure 21. Allergan Recent Developments and Future Plans
Figure 22. AbbVie Inc. Recent Developments and Future Plans
Figure 23. Merck KGaA Recent Developments and Future Plans
Figure 24. RLC Labs Recent Developments and Future Plans
Figure 25. GlaxoSmithKline Plc Recent Developments and Future Plans
Figure 26. Mylan Recent Developments and Future Plans
Figure 28. Global Thyroid Disorder Revenue Share by Players in 2020
Figure 29. Thyroid Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 30. Global Top 3 Players Thyroid Disorder Revenue Market Share in 2020
Figure 31. Global Top 10 Players Thyroid Disorder Revenue Market Share in 2020
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 33. Global Thyroid Disorder Revenue Share by Type in 2020
Figure 34. Global Thyroid Disorder Market Share Forecast by Type (2021-2026)
Figure 35. Global Thyroid Disorder Revenue Share by Application in 2020
Figure 36. Global Thyroid Disorder Market Share Forecast by Application (2021-2026)
Figure 37. North America Thyroid Disorder Sales Market Share by Type (2016-2026)
Figure 38. North America Thyroid Disorder Sales Market Share by Application (2016-2026)
Figure 39. North America Thyroid Disorder Revenue Market Share by Country (2016-2026)
Figure 40. United States Thyroid Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Thyroid Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Thyroid Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Thyroid Disorder Sales Market Share by Type (2016-2026)
Figure 44. Europe Thyroid Disorder Sales Market Share by Application (2016-2026)
Figure 45. Europe Thyroid Disorder Revenue Market Share by Country (2016-2026)
Figure 46. Germany Thyroid Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Thyroid Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Thyroid Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Thyroid Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Thyroid Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Thyroid Disorder Sales Market Share by Type (2016-2026)
Figure 52. Asia-Pacific Thyroid Disorder Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Thyroid Disorder Revenue Market Share by Region (2016-2026)
Figure 54. China Thyroid Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Japan Thyroid Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. South Korea Thyroid Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. India Thyroid Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Southeast Asia Thyroid Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Australia Thyroid Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South America Thyroid Disorder Sales Market Share by Type (2016-2026)
Figure 61. South America Thyroid Disorder Sales Market Share by Application (2016-2026)
Figure 62. South America Thyroid Disorder Revenue Market Share by Country (2016-2026)
Figure 63. Brazil Thyroid Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Argentina Thyroid Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Middle East and Africa Thyroid Disorder Sales Market Share by Type (2016-2026)
Figure 66. Middle East and Africa Thyroid Disorder Sales Market Share by Application (2016-2026)
Figure 67. Middle East and Africa Thyroid Disorder Revenue Market Share by Country (2016-2026)
Figure 68. Turkey Thyroid Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Saudi Arabia Thyroid Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. UAE Thyroid Disorder Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source